Peter Meeus
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 7
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments 5
- Acute Myeloid Leukemia Research 4
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 4
-
- Immunodeficiency and Autoimmune Disorders 3
-
- Viral-associated cancers and disorders 3
-
- Atrial Fibrillation Management and Outcomes 2
-
- Sepsis Diagnosis and Treatment 2
Peter Meeus
20 papers receiving 373 citations
Peers
Comparison fields: 5 of 53
- Genetics 169
- Hematology 122
- Pathology and Forensic Medicine 121
- Internal Medicine 24
- Immunology 95
Countries citing papers authored by Peter Meeus
This map shows the geographic impact of Peter Meeus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Meeus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Meeus more than expected).
Fields of papers citing papers by Peter Meeus
This network shows the impact of papers produced by Peter Meeus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Meeus. The network helps show where Peter Meeus may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Meeus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 4 | |
| 2 | 2022 | 17 | |
| 3 | 2022 | 5 | |
| 4 | 2021 | 9 | |
| 5 | 2019 | 35 | |
| 6 | 2012 | 22 | |
| 7 | 2011 | 28 | |
| 8 | 2010 | 1 | |
| 9 | 2010 | 8 | |
| 10 | Application of the international scoring system (IPSS) for myelodysplastic syndromes (MDS) | 1998 | 1 |
| 11 | 1997 | 86 | |
| 12 | 1997 | 12 | |
| 13 | 1997 | 2 | |
| 14 | 1997 | 36 | |
| 15 | Trisomy 13 in myeloid malignancies: Clinical, morphologic and immunologic correlations and characterization by combined immunophenotyping and interphase fluorescence in situ hybridization (FISH). | 1996 | 2 |
| 16 | 1996 | 44 | |
| 17 | 1996 | 12 | |
| 18 | 1996 | 35 | |
| 19 | 1995 | 1 | |
| 20 | 1992 | 25 |
About Peter Meeus
Peter Meeus is a scholar working on Genetics, Hematology, Critical Care and Intensive Care Medicine, Internal Medicine and Pathology and Forensic Medicine, having authored 20 papers that have together received 385 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (7 papers), Chronic Myeloid Leukemia Treatments (5 papers), Acute Myeloid Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Viral-associated cancers and disorders (3 papers), Atrial Fibrillation Management and Outcomes (2 papers) and Sepsis Diagnosis and Treatment (2 papers). The work is most often cited by research in Genetics (169 citations), Hematology (122 citations), Pathology and Forensic Medicine (121 citations), Internal Medicine (24 citations) and Immunology (95 citations). Peter Meeus has collaborated with scholars based in Belgium, Italy and United States. Frequent co-authors include Gregor Verhoef, Lucienne Michaux, Herman Van den Berghe, A. Criel, Cristina Mecucci, Els Bailleul, A. Louwagie, Glynis Frans, Michel Stul and Angeline Van Orshoven. Their work appears in journals such as British Journal of Haematology, Blood, Genes Chromosomes and Cancer, Clinica Chimica Acta and Clinical Chemistry and Laboratory Medicine (CCLM).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.